27 results
SC TO-T/A
THRX
Theseus Pharmaceuticals Inc
7 Feb 24
Third party tender offer statement (amended)
5:15pm
’ estimate of the Disposition Proceeds is based on the co-offerors’ assessment of the CVR Products together with Theseus’ independent estimate. The CVR
UPLOAD
THRX
Theseus Pharmaceuticals Inc
2 Feb 24
Letter from SEC
12:00am
'
assessment of the CVR Products." While you explain that Theseus did
not receive any
proposals during
SC TO-T/A
EX-99
Concentra Merger Sub II, Inc.
30 Jan 24
Third party tender offer statement (amended)
8:23am
per CVR in Further Savings Proceeds.
The co-offerors’ estimate of the Disposition Proceeds is based on the co-offerors’ assessment of the CVR Products
SC 14D9
THRX
Theseus Pharmaceuticals Inc
10 Jan 24
Tender offer solicitation
9:47am
such Disposition Period;
Prospects of the Company on a Standalone Basis. The Theseus Board’s assessment of the business, operations, prospects, strategic … of experts, to be charged pro rata against the value of all Shares entitled to appraisal. In the absence of such determination or assessment, each party
SC TO-T
EX-99
Concentra Merger Sub II, Inc.
10 Jan 24
Third party tender offer statement
8:51am
Savings Proceeds.
The co-offerors’ estimate of the Disposition Proceeds is based on the co-offerors’ assessment of the CVR Products together
SC TO-T
EX-99
yjap9zpom8c0ygd9t9x
10 Jan 24
Third party tender offer statement
8:51am
8-K
EX-2.1
pzsu lex7z6lq
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
8-K
EX-99.2
87rj 7u4brsckp
25 May 23
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST
5:04pm
PRE 14A
e37kjtpbijrsu9mv
14 Apr 23
Preliminary proxy
9:00am
S-3
8msrevhw0mkm38
3 Nov 22
Shelf registration
9:06am
S-3
EX-4.5
he4i7m5
3 Nov 22
Shelf registration
9:06am
S-3
EX-1.2
zlk jawp8
3 Nov 22
Shelf registration
9:06am
S-3
EX-4.6
q1nlarp h69c9id3g73
3 Nov 22
Shelf registration
9:06am
DEF 14A
whkdm6l
25 Apr 22
Definitive proxy
4:30pm
10-K
5og9623yjqnldtpj
10 Mar 22
Annual report
7:23am
10-Q
bhefnhy24
15 Nov 21
Quarterly report
7:36am
424B4
5d9 60bwkt
7 Oct 21
Prospectus supplement with pricing info
5:03pm
S-1/A
EX-1.1
3jah1f1edsc9tv
30 Sep 21
IPO registration (amended)
6:33am